ArticleBiomacromolecules2026
Contrast Agent Design to Deliver Improved Ultrasound Echogenicity from Medical Devices: A Route to In-Ward Device Placement Tracking.
Article in Biomacromolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This work reports a scalable strategy for producing polymeric medical devices with enhanced ultrasound (US) echogenicity via tailored dispersant design to support safer image-guided medical device placement. Real-time US imaging offers an alternative to X-ray imaging, reducing radiation exposure while enabling accurate device positioning/monitoring. Previous studies showed that including bioabsorbable phosphate-based glass (PBG) microspheres into thermoplastic polyurethane (TPU) could improve echogenicity. However, aggregation and processing defects limited the performance. To address this, two classes of acid-functionalized dispersants were synthesized to improve the microsphere dispersion and compatibility with TPU. These, i.e., dodecenylsuccinic diacid (DDSD) and oligomeric methacrylate/acrylates prepared using acid-functionalized chain-transfer agents, were grafted onto PBG microspheres via dip-coating and thermal treatment. Successful surface modification was confirmed by separation testing, SEM, and XPS. TPU composites containing the coated microspheres were then extruded into catheter-like structures and shown to demonstrate enhanced, more uniform echogenicity under clinical US imaging conditions without compromising the mechanical properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.